Williamstown, MA -- (SBWIRE) -- 02/28/2012 -- GlobalData's new report, "Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery" provides key market data on the Asia-Pacific Diabetes Care Devices market - Australia, China, India and Japan. The report provides value (USD million) data for all the market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

View Full Report Details and Table of Contents

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Australia, China, India and Japan.
- Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Diabetes Care Devices market..
- Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, LifeScan, Inc., Eli Lilly and Company, ARKRAY, Inc., Medtronic, Inc. and others.

Reasons To Get This Report

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Asia-Pacific Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned in this Report: F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, LifeScan, Inc., Eli Lilly and Company, ARKRAY, Inc., Medtronic, Inc., Sanofi, Abbott Laboratories, Bayer HealthCare AG, Terumo Corporation, Becton, Dickinson and Company, Animas Corporation, Hindustan Syringes & Medical Devices Ltd., NIPRO CORPORATION, B. Braun Melsungen AG

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
- Taiwan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
- Saudi Arabia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
- South Africa Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
- Republic of Korea Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
- India Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
- United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
- Canada Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
- Mexico Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
- Australia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery